216 related articles for article (PubMed ID: 35377213)
1. Genomic Insights into Achromobacter mucicolens
Al-Asadi SA; Al-Kahachi RES; Alwattar WMA; Bootwala J; Sabbah MA
Microbiol Spectr; 2022 Apr; 10(2):e0191621. PubMed ID: 35377213
[TBL] [Abstract][Full Text] [Related]
2. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.
Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B
Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic and environmental variables on biofilm development dynamics in
Al-Kahachi R; Al-Asadi S; Ali ZO; Rampurawala J
Iran J Microbiol; 2023 Jun; 15(3):414-424. PubMed ID: 37448677
[TBL] [Abstract][Full Text] [Related]
4. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.
Jakobsen TH; Hansen MA; Jensen PØ; Hansen L; Riber L; Cockburn A; Kolpen M; Rønne Hansen C; Ridderberg W; Eickhardt S; Hansen M; Kerpedjiev P; Alhede M; Qvortrup K; Burmølle M; Moser C; Kühl M; Ciofu O; Givskov M; Sørensen SJ; Høiby N; Bjarnsholt T
PLoS One; 2013; 8(7):e68484. PubMed ID: 23894309
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a novel β-lactamase gene,
Zhang Y; Zhao J; Zhang G; Lin N; Sha Y; Lu J; Zhu T; Zhang X; Li Q; Zhang H; Lin X; Li K; Bao Q; Li D
Front Microbiol; 2023; 14():1252427. PubMed ID: 37808287
[TBL] [Abstract][Full Text] [Related]
6. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
[No Abstract] [Full Text] [Related]
7. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla
Zhu Z; Xu J; He F
J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and variability of siderophore production in the
Sorlin P; Brivet E; Jean-Pierre V; Aujoulat F; Besse A; Dupont C; Chiron R; Jumas-Bilak E; Menetrey Q; Marchandin H
Microbiol Spectr; 2024 Mar; 12(3):e0295323. PubMed ID: 38315029
[No Abstract] [Full Text] [Related]
9. Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans.
Magallon A; Amoureux L; Garrigos T; Sonois M; Varin V; Neuwirth C; Bador J
J Antimicrob Chemother; 2022 Mar; 77(4):926-929. PubMed ID: 35029278
[TBL] [Abstract][Full Text] [Related]
10.
Gabrielaite M; Nielsen FC; Johansen HK; Marvig RL
Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34232117
[No Abstract] [Full Text] [Related]
11.
Isler B; Kidd TJ; Stewart AG; Harris P; Paterson DL
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816734
[No Abstract] [Full Text] [Related]
12. Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii.
Ruiz C; McCarley A; Espejo ML; Cooper KK; Harmon DE
mSphere; 2019 Oct; 4(5):. PubMed ID: 31578249
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of OXA-258 enzymes and AxyABM efflux pump in Achromobacter ruhlandii.
Papalia M; Traglia G; Ruggiero M; Almuzara M; Vay C; Gutkind G; Ramírez MS; Radice M
J Glob Antimicrob Resist; 2018 Sep; 14():233-237. PubMed ID: 29649588
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant
Okoliegbe IN; Hijazi K; Cooper K; Ironside C; Gould IM
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816722
[No Abstract] [Full Text] [Related]
15. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection.
Veschetti L; Boaretti M; Saitta GM; Passarelli Mantovani R; Lleò MM; Sandri A; Malerba G
Microbiol Res; 2022 Oct; 263():127140. PubMed ID: 35931003
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone-resistant Achromobacter xylosoxidans clinical isolates from Serbia: high prevalence of the aac-(6')-Ib-cr gene among resistant isolates.
Lilić B; Filipić B; Malešević M; Novović K; Vasiljević Z; Kojić M; Jovčić B
Folia Microbiol (Praha); 2019 Mar; 64(2):153-159. PubMed ID: 30105450
[TBL] [Abstract][Full Text] [Related]
17.
Sandri A; Veschetti L; Saitta GM; Passarelli Mantovani R; Carelli M; Burlacchini G; Preato S; Sorio C; Melotti P; Montemari AL; Fiscarelli EV; Patuzzo C; Signoretto C; Boaretti M; Lleò MM; Malerba G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012535
[No Abstract] [Full Text] [Related]
18. Isolation, identification and whole-genome analysis of an Achromobacter strain with a novel sulfamethazine resistance gene and sulfamethazine degradation gene cluster.
Zeng L; Du H; Lin X; Liao R; Man Y; Fang H; Yang Y; Tao R
Bioresour Technol; 2024 May; 399():130598. PubMed ID: 38493935
[TBL] [Abstract][Full Text] [Related]
19. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.
Bador J; Amoureux L; Blanc E; Neuwirth C
Antimicrob Agents Chemother; 2013 Jan; 57(1):603-5. PubMed ID: 23089757
[TBL] [Abstract][Full Text] [Related]
20. AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.
Pongchaikul P; Santanirand P; Antonyuk S; Winstanley C; Darby AC
FEMS Microbiol Lett; 2020 Jul; 367(14):. PubMed ID: 32592387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
